Turner Investments’s Globus Medical GMED Stock Holding History

Turner Investments’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-5,000	Closed	-$166K	–	141
2017 Q2	$166K	Buy	+5,000	New	+$157K	0.11%	206

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VBA

Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Turner Investments's GMED Position: Q3 2017 in Review

Turner Investments sold out of Globus Medical (GMED) in Q3 2017, closing a stake of 5,000 shares — an estimated $166K sold.

Turner Investments first reported a position in GMED in Q2 2017 and held it in 1 quarter. The position peaked at $166K in Q2 2017. 253 funds tracked by Wall St. Rank hold GMED as of Q3 2017.

Turner Investments reported no remaining Globus Medical position as of Q3 2017 after selling out during the quarter.
Turner Investments sold 5,000 Globus Medical shares in Q3 2017, an estimated $166K.
Turner Investments first reported a position in Globus Medical in Q2 2017 and held it in 1 quarter.
Turner Investments's Globus Medical position peaked at $166K in Q2 2017.
253 funds tracked by Wall St. Rank held Globus Medical as of Q3 2017.

Based on Turner Investments's 13F filing for Q3 2017, filed 8 Nov 2017.